The capsular polysaccharide of Hemophilus influenzae type b, polyribosyl ribitol phosphate (PRP), is released from growing organisms during human infection and can be found in body fluids. It binds to untreated erythrocytes. Many patients with invasive infections with this organism develop significant hemolysis, but the mechanism has been unclear. We have found that PRP binds to human erythrocytes in vivo. PRP-coated erythrocytes have a shortened circulation time in mice, but do not lyse spontaneously or fix complement. PRP-coated erythrocytes exposed to antiserum to H. influenzae type b are undamaged in the absence of complement, but are rapidly and effectively lysed in the presence of an intact complement system both in vitro and in vivo in mice. PRP-coated red cells are taken up by liver and spleen. Antiserum to PRP increases hepatic uptake of PRP-coated red cells more than splenic, and appears to induce intravascular, complementmediated hemolysis, as well as extravascular hemolysis. Patients with invasive infection develop hemolysis when circulating PRP and antibody to PRP are present simultaneously. PRP can sometimes be detected on patient erythrocytes when free PRP is present in serum, but this is an inconsistent finding. The hemolytic anemia that occurs during human infection with H. influenzae type b may be due to absorption of PRP to red cells and immune destruction of sensitized erythrocytes. The process requires an intact complement system; both complement-mediated cell lysis and extravascular hemolysis contribute to red cell destruction.
Introduction
Many bacterial species contain antigens that can be adsorbed to untreated erythrocytes and render these modified red cells agglutinable by antibodies to the bacterial antigens. Most, if not all, of these substances are polysaccharides or contain polysaccharides as the antigenically relevant constituent (1) . Protein antigens may be adsorbed to red cells treated with tannic acid ("tanned erythrocytes"), but do not bind well to untreated red cells (2) . The adsorption of Hemophilus influenzae type b polysaccharides to erythrocytes was described in 1947 (3) , and was for many years the basis ofimmunologic studies ofthis organism utilizing passive hemagglutination techniques. H. influenzae type b releases its capsular polysaccharide, polyribosyl ribotyl phosphate (PRP)' into the culture medium in which it is grown, and into biological fluids such as blood and cerebrospinal fluid (CSF) during natural infections. PRP is the major virulence factor of H. influenzae type b, and is responsible for enabling the organism to evade phagocytosis, as it does not bind to phagocytic cells and does not activate the alternative pathway of complement (4) . Antibody to PRP protects against laboratory and natural infections (5, 6) . PRP is poorly immunogenic in young children who experience the majority ofinfectious episodes, but is effective as a vaccine against H. influenzae type b infections in most older children and adults (7, 8) . An association between anemia and H. influenzae type b meningitis was first noted because of a high frequency of blood transfusions given to these patients (9, 10) . No difference in the severity of anemia was found between patients treated with specific rabbit serum and patients who did not receive the antiserum. A subsequent report attributed hemolytic anemia to administration of immune rabbit serum; many of these patients developed spherocytosis on peripheral blood smear (1 1). Both reports noted more severe anemia in patients with more severe infectious illnesses. Subsequent studies have confirmed this observation, and noted that anemia on admission is more common in patients with longer prodromal illness (12) . The erythrocytes of patients with H. influenzae type b meningitis have been found to be less deformable and to have higher levels of carboxyhemoglobin than erythrocytes from patients with other forms of meningitis or from uninfected persons (13) . The hemolytic nature of the anemia has been noted, and the possibility that adsorbed bacterial toxins contribute to red cell destruction has been suggested by several authors (10, 12) . Hypoferremia secondary to acute infection may contribute to the lack of erythropoiesis in response to anemia (14) .
The present study explores the effects of exposure to supernatants of H. influenzae type b cultures and purified PRP on survival of erythrocytes, and the interaction of erythrocytes coated with adsorbed PRP with antibody and with complement. We have found that PRP adsorbs to erythrocytes in vivo during naturally occurring human infections. PRP-coated erythrocytes have a shortened in vivo survival in mice. In the presence of antibody and complement, brisk hemolysis can be demonstrated in vitro and in vivo. In mice, the liver and spleen are the sites of red cell destruction. In patients with systemic H. influenzae type b infections, hemolysis occurs when circulating PRP coincides with antibody production. The simultaneous presence ofadsorbed bacterial antigen, specific antibody, and complement on the surface of the red cell result in hemolytic anemia.
Methods
Bacterial supernatants. H. influenzae type b, strain Eagan, was grown to log phase or overnight in culture broth (15) , and the medium was sterilized by passage through a Millipore filter (Millipore Corp., Bedford, MA). Medium in which no bacteria had been grown was used as a control.
Supernatants from strain Eagan and from a variant, Eagan S-2, which releases -1% of the PRP released by Eagan, were used (15) . PRP was prepared from the bacterial supernatant as previously described (16 Three sources of complement were used. Fresh guinea pig serum was found to contain no detectable antibody to PRP by hemagglutination and did not lyse PRP-coated human erythrocytes in the absence of antibody to PRP. Agammaglobulinemic human serum contained no antibody to PRP by hemagglutination, but samples obtained up to 6 wk after gamma-globulin injection contained sufficient isohemagglutinins to produce some lysis of type A or type B erythrocytes. These sera did not lyse type 0 erythrocytes. C7-deficient human serum was obtained from a patient with no detectable C7 (19) , and absorbed with H. influenzae type b at 00C for 60 min twice prior to use. All samples were separated within 90 min of collection, and stored at -90'C in aliquots.
Passive hemagglutination assayfor detection ofantibody to PRP and PRP on patient erythrocytes. A modification of published methods was employed (17) . Fresh human type 0 Rh-negative erythrocytes were collected in acid-citrate-dextrose and washed three times in phosphate-buffered saline (PBS). They were stored up to 2 wk at 4VC in Alsever's solution. For antigen sensitization, the cells were suspended in PBS at 1.2% (vol/vol) with 5.0 Mg of PRP/ml, incubated 1 h at 370C, washed three times with PBS to remove unabsorbed antigen, and suspended in PBS at 0.6%. The binding of PRP to the cell surface was stable for at least 2 wk, but sensitized cells were usually freshly prepared. Patient cells were stored up to 5 d in Alsever's solution. Serial twofold dilutions of 25 Ml of test serum in PBS with 0.25% bovine serum albumin (BSA) were prepared in U-bottomed microtiter trays, and 25 Ml ofcell suspension was added. As a control for nonspecific agglutination, each serum was diluted in duplicate with unsensitized type 0, Rh-negative red cells. The trays were sealed, mixed, and incubated for 1 h at 37°C. Agglutination was read by tipping the tray to a vertical position and observing for several minutes. Unaggregated cells flowed smoothly downward in a stream, and aggregated cells adhered to the bottom or fell together as a clump. The same red cell donor was used for all assays reported because minor variability in titers was found when cells from different type 0 donors were used.
Detection of PRP in patient samples. Serum PRP was assayed by latex agglutination (Walpole Laboratories, Cranbury, NJ) (20) . PRP was detected on the surface ofpatient erythrocytes by hemagglutination with rabbit antiserum. Washed patient cells were incubated in U-bottomed microtiter plates with dilutions of rabbit antiserum to H. influenzae type b, using nonimmune rabbit serum, PRP-coated human erythrocytes, and untreated erythrocytes as controls.
Measurement ofPRP in culture supernatants. PRP was measured in the filtered supernatants of log phase and overnight cultures of H. influenzae type b by radioantigen binding inhibition (21) .
Immune hemolysis ofpatient cells. To determine whether adsorbed bacterial antigens not demonstrable by hemagglutination might be present, patient red cells were incubated with immune rabbit serum and guinea pig complement for 60 min at 37°C, and free hemoglobin was measured in the supernatant by measuring absorbance at 560 nm. Patient cells were incubated simultaneously with nonimmune rabbit serum to determine nonspecific release of hemoglobin. Immune hemolysis was considered to be present when the mean absorbance of the supernatant of cells incubated with immune serum was greater than 2 standard deviations (SD) above the mean absorbance of the supernatant of cells incubated with nonimmune serum and complement.
Preparation ofphagocytes. Monocytes were prepared from buffy coat preparations obtained from freshly prepared human platelet packs obtained on a Celltrifuge cell separator (Fenwal, Deerfield, IL) in the University Hospitals Blood Bank. The mononuclear cell layer was prepared on a Ficoll-Hypaque gradient (22) , and depleted of T lymphocytes by rosetting with sheep erythrocytes (23) . The resulting preparation contained 82-86% esterase-positive cells, which were suspended to I X 10'/ml mixed, and incubated for I h at 37°C. The cells were then pelleted, and the supernatant aspirated and counted in a gamma-counter (Packard Instrument Co., Downers Grove, IL) to determine spontaneous and serum-dependent 5"Cr release. The cell pellet was resuspended with 1 X I0' monocytes or neutrophils in 0.1 ml, the trays were resealed, and incubation continued for 2 h at 37°C. The cells were pelleted, and the supernatant fluid aspirated and counted to determine extracellular release of5Cr. Free erythrocytes were lysed with 0.87% NH4CI, and the phagocyte pellet was counted to determine intracellular 5"Cr, or erythrophagocytosis.
Results were expressed as the percentage ofcounts in the sample compared to the counts released by 3% acetic acid (100% lysis).
Particle ingestion. Emulsions of phthalate oil containing oil red 0 and stabilized with 20 mg of gelatin/ml were prepared by sonication by a modification ofthe method of Stossel et al. (24) . Particles were prepared with culture medium, with H. influenzae type b culture supernatant, and with 5.0 Mg of PRP/ml PBS with 1 mM Ca2+ and Mg2e. Antigencoated oil droplets were opsonized with rabbit antiserum to H. influenzae type b, guinea pig complement, C7-deficient human serum, or with both antibody and complement for 30 min at 37°C, and then fed to neutrophils and monocytes for 5 min at 37°C. Uningested oil droplets were removed by centrifugation; the ingested dye-containing oil was extracted from the washed cell pellet with dioxane and quantitated spectrophotometrically at 524 nm.
In vivo survival oferythrocytes in mice. Adult inbred C57 black mice weighing 27-29 g were bled by retroorbital puncture. Blood was obtained in acid-citrate-dextrose from two mice and labeled with 51Cr as described above. Control erythrocytes were treated with Hanks' BSS. PRP-coated red cells were prepared by incubation with 5.0 Mg of PRP/ml for I h at 37°C. Opsonized erythrocytes were prepared by treating PRP-coated red cells with heat-inactivated rabbit anti-H. influenzae type b antiserum for 30 min at 4°C. Four to six mice in each group were injected with 0.03 ml of packed labeled erythrocytes, or -3 X 101 red cells per mouse, into the tail vein. Duplicate samples of 0.025 ml of blood were obtained by retroorbital puncture beginning immediately after injection. The initial sample was designated zero time, and considered to represent 100% survival for purposes of comparison with subsequent samples. The total dose of 5"Cr administered was calculated by assuming a total blood volume of 2.5 ml per mouse. The 0.025-ml sample volume represents 1% of the total blood volume. 5 d after injection, animals were killed, and liver, spleen, lungs, and kidneys were removed. All organs were weighed and counted in a gamma-counter.
Patient material. A retrospective chart review was made to ascertain the prevalence ofanemia in septicemic children. All patients with positive blood cultures were identified from a chronological log maintained in the Bacteriology Laboratory at Rainbow Babies' and Children's Hospital; patients with positive cultures between 1 January 1982 and 30 June 1983 were included. Hospital charts were reviewed to determine the prevalence of anemia. Where hospital charts could not be located, laboratory data was retrieved from computerized reports in the central Hematology laboratory at University Hospitals of Cleveland. Names and hospital numbers were checked against records of patients with known hemoglobinopathies and malignancies maintained in the Pediatric Hematology office. Blood smears were reviewed on all patients, and microcytosis and evidence of hemoglobinopathy were specifically noted. Anemia was defined as hemoglobin values less than 2 SD below the mean normal for age (25) . Because not all patients had repeat blood counts performed, our data represent the minimum prevalence of anemia in this population. Where serial blood counts were obtained, a decrease in hemoglobin of >0.5 g/dl per 24 h was considered significant even if the hemoglobin did not fall below the normal range.
10 patients were studied prospectively after blood cultures yielded 26 Mg of PRP/ml at log phase, and 160 ,ug/ml when grown overnight, while supernatants of strain Eagan S-2 contained 0.17 ,ug of PRP/ml at log phase and 2.8 Mg of PRP/ml when grown overnight. Erythrocytes treated with culture media without bacterial antigens did not undergo lysis in the presence or absence ofantibody and complement, implying that the hemolytic properties were due to bacterial products. The dependence of hemolysis upon terminal complement components was demonstrated by the failure ofC7-deficient serum to induce chromium release in the presence of antibody.
Antibody-dependent, complement-mediated hemolysis was proportional to the concentration of PRP with which erythrocytes were pretreated (Fig. 1) . Neither hemagglutination nor specific 5'Cr release was detectable <0.025 Mg of PRP/ml. The extent of 5tCr release increased with the PRP concentration up to 5.0 ,ug/ml, above which further increases did not induce more extensive hemolysis. Supernatants from H. influenzae type b strain Eagan S-2 grown to log phase containing 0.17 ,ug of PRP/ ml induced 15% 5'Cr release from sensitized red cells treated with antibody and complement. Supernatants from overnight cultures of Eagan S-2 containing 2.8 Mg of PRP/ml induced as much hemolysis as supernatants from Eagan at log phase or overnight, and as much as 5 Mg of purified PRP/ml.
Neither monocytes nor neutrophils induced extracellular hemolysis during a 2-h incubation with sensitized erythrocytes exposed to antiserum or C7-deficient serum. Erythrophagocytosis by monocytes and polymorphonuclear leukocytes (PMN) could not be demonstrated in the presence ofantiserum or complement alone. When both antiserum and intact complement were present, hemolysis was virtually complete, and ingestion could not be assessed.
Quantitative ingestion of oil droplets containing bacterial antigens was greatly enhanced by treatment ofthe particles with both antiserum and complement (Table II) . Gelatin particles were ingested by both monocytes and neutrophils at a low rate without opsonization. The rate ofparticle ingestion was enhanced by antiserum and complement only if bacterial supernatant or PRP was present. Phagocytosis of oil droplets was enhanced by bacterial supernatants which contained only small amounts of PRP. Eagan S-2 log-phase supernatants increased antibody-mediated ingestion as much as supernatants from S-2 overnight, Eagan log-phase and Eagan overnight cultures, although it in- duced suboptimal complement-mediated immune hemolysis of erythrocytes (Table I) . In vivo erythrocyte survival and hemolysis. Treatment of red blood cells with PRP resulted in rapid clearance of 12% of the cells from the circulation of mice (Fig. 2) Anemia was also more severe in patients with H. influenzae type b infections (Table IV) . No patients with septicemia resulting from other organisms had hemoglobin values <9 g/dl, while Fig. 3 . Of the four nonanemic patients, three were <1 yr of age (Table VI) . Two of the infants had persistent antigenemia detectable beyond the third hospital day; the third cleared circulating PRP by the second hospital day, but only one ofthe three infants developed detectable antibody to PRP by the time of discharge 2 wk after admission. The course of one of these patients is shown in Fig. 4 . The fourth patient, aged 19 mo, had no detectable PRP in serum on admission, and had measurable antibody to PRP on the third hospital day. In none of these patients were circulating PRP and antibody to PRP detectable simultaneously. All four patients who did not develop anemia had serum haptoglobin >100 mg/dl, normal CH", negative direct antiglobulin tests, and urine negative for hemoglobin and hemosiderin.
In vitro immune hemolysis of patient red cells could be demonstrated in all three patients in whom passive hemagglutination indicated that PRP was present on the surface of the red cells, and in an additional three patients with negative hemagglutination tests. In all patients in whom in vitro immune hemolysis was present, PRP was identifiable in simultaneous serum samples. PRP could not be identified on two patients' erythrocytes despite its presence in serum. In vitro immune hemolysis was more likely to be demonstrable early in the patient's hospitalization, and did not persist in any patient beyond the third hospital day. Thus, in vivo sensitization of red cells was an inconsistent accompaniment of antigenemia.
Discussion
The capsular polysaccharide, PRP, is a critical virulence factor in systemic infections with H. influenzae type b. PRP is poorly antigenic in young children, a feature that limits the use of PRP as a vaccine to children over the age of2 yr (6) (7) (8) . During systemic infection, PRP is released into the circulation, and can be found in blood, urine, and CSF of patients with meningitis (21) . In patients treated with antibiotics, bacteremia usually clears rapidly, but PRP can be detected for varying lengths of time after sterilization of blood. Some patients clear PRP from the blood within a few days ofinstitution ofeffective therapy, while others have prolonged antigenemia that may persist beyond the time ofdischarge from the hospital, long after they are clinically well. Prolonged antigenemia is most frequent in children who do not develop an antibody response, and in those who have a severe clinical course. Patients with prolonged antigenemia who develop an antibody response have both free PRP and PRP complexed to antibody demonstrable in the presence offree antibody specific for PRP (21) .
Complement activation by PRP requires the presence of specific antibody (4). The failure of purified PRP to activate the alternative pathway of complement may account for the virulence of type b compared to the other five serotypes of H. influenzae, a and c-f (27) (28) (29) . Somatic antigens may activate the alternative pathway of complement, but are largely unexposed in the presence of an intact capsule. Complement is not activated by whole organisms in EGTA-chelated serum. The lack of non- immune complement-mediated lysis ofred cells exposed to crude bacterial supernatants suggests that somatic antigens released into the culture medium (30) either are not adsorbed to erythrocytes under these conditions or do not activate the alternative pathway ofcomplement once adsorbed to the erythrocytes. Logphase bacterial culture supernatants ofstrain Eagan contain five times, and overnight culture supernatants contain over 30 times as much PRP as is needed to produce maximal erythrocyte sensitization in a purified state (15, 31) . Culture supernatants of Eagan S-2, a variant strain of Hib producing 1% of the PRP released by wild-type strain Eagan, induced a lower level of immune hemolysis that was slightly higher than that induced by purified PRP at a concentration equivalent to that present at log phase. Overnight Eagan S-2 culture supernatants induced the maximal extent of hemolysis, corresponding to that seen with an equivalent concentration of purified PRP. The fact that PRP and supernatant induce identical patterns of hemolysis, and that the extent ofhemolysis depends on the amount ofPRP released by the organisms, strongly suggests that PRP is the major antigen in the bacterial supernatant which adsorbs to erythrocytes and shortens their survival in vivo.
The ability of certain viruses, bacteria, and bacterial products to adsorb to erythrocytes has been known for many years. Staphylococcus aureus and Vibrio cholera directly induce clumping of red cells (1) . Hemagglutination and hemolysis of coated erythrocytes in the presence of antibodies to adsorbed antigens have been the basis of many assays in microbiology developed long before either the antigens or the antibodies were characterized. Immune agglutination ofred cells in the presence of adsorbed bacterial products was first described in 1947 using H. influenzae type b (3). Virtually all ofthe substances that adsorb to untreated erythrocytes are polysaccharides or lipopolysaccharides (1, 32) .
Although the ability ofbacterial products to adsorb to erythrocytes in vitro is a useful laboratory tool, it does not imply that similar phenomena occur in vivo, or that survival of coated erythrocytes is in any way affected. The Vi antigen ofSalmonella adsorbs to red cells of many species of animals. Injection of Vi antigen-coated erythrocytes into rabbits stimulates production of antiserum with anti-Vi specificity, devoid of antibodies to other Salmonella antigens (33) . This appears to be an effective method ofantigen presentation. Sensitized erythrocytes are rap- (38) . In several disease entities, specific interaction between the products of microorganisms and components of the host immune system with erythrocytes appears to contribute significantly to development of hemolytic anemia (1, 30) . The Adsorption of antigen-antibody complexes to the red cell surface with in vivo sensitization has also been demonstrated in patients with African trypanosomiasis (44) and kala azar (45) , and in Trypanosoma bruceii-infected mice (46) . In these instances ofin vivo sensitization, IgM, IgG, and complement have all been found on the red cell surface in varying combinations. Although none of the antigens were purified or characterized, antigen alone did not appear to bind to erythrocytes. Antigenantibody complexes were formed and bound to the red cells of these patients and animals. 5"Cr-labeled erythrocytes were concentrated in the spleens of these patients. An asplenic patient with kala azar did not develop anemia despite heavy infection (45) . Acute hemolysis with positive direct antiglobulin test has also been reported in three children after diphtheria-pertussistetanus vaccination (47) . Both tetanus and diphtheria toxoids bind to erythrocytes, but hemolytic complications are exceed-C Anemira ingly rare. 
